Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Magenta Therapeutics, Inc. | d76599dex321.htm |
| EX-31.2 - EX-31.2 - Magenta Therapeutics, Inc. | d76599dex312.htm |
| EX-31.1 - EX-31.1 - Magenta Therapeutics, Inc. | d76599dex311.htm |
| EX-23.1 - EX-23.1 - Magenta Therapeutics, Inc. | d76599dex231.htm |
| EX-21.1 - EX-21.1 - Magenta Therapeutics, Inc. | d76599dex211.htm |
| EX-10.14.2 - EX-10.14.2 - Magenta Therapeutics, Inc. | d76599dex10142.htm |
| EX-10.10.7 - EX-10.10.7 - Magenta Therapeutics, Inc. | d76599dex10107.htm |
| EX-10.10.5 - EX-10.10.5 - Magenta Therapeutics, Inc. | d76599dex10105.htm |
| 10-K - 10-K - Magenta Therapeutics, Inc. | d76599d10k.htm |
Exhibit 10.10.4
AMENDMENT #2
TO
PROJECT RIDER #1
COLLABORATION AGREEMENT
This Amendment #2 to Project Rider #1 (“Amendment #2”) is entered into effective as of the date of the final signature executing this Amendment #2 (“Amendment #2 Effective Date”) by and between Magenta Therapeutics, Inc. (“Magenta”) and National Marrow Donor Program d/b/a Be The Match Biotherapies (“BTMB”) (each a “Party” and collectively the “Parties”).
WHEREAS, the Parties executed a Collaboration Agreement, effective November 10, 2017 and a Project Rider, effective December 6, 2017 (as amended by that certain Amendment #1, effective December 6, 2018, “Project Rider #1”); and
WHEREAS, the Parties agree to revise the Payment Schedule of the Project Rider #1.
NOW, THEREFORE, for the valuable consideration contained herein, and intending to be legally bound, Magenta and BTMB agree to the following amendment to be effective as of the Amendment #2 Effective Date as follows:
Amendment to Project Rider #1
| 1. | Delete the Payment Schedule in Section D. Compensation of BTMB of Project Rider #1 in its entirety and replace it with the following to read as follows: |
PAYMENT SCHEDULE
| For Services provided by BTMB during Calendar Year 2020 (January 1, 2020 through December 31, 2020), Magenta will pay BTMB a fixed price quarterly payment of $25,000. | BTMB will invoice $25,000 every January 15th for consulting services occurring during the period commencing January 1st and ending March 31st.
BTMB will invoice $25,000 every April 15th for consulting services commencing April 1st and ending June 30th.
BTMB will invoice $25,000 every July 15th for consulting services commencing July 1st and ending September 30th.
BTMB will invoice $25,000 every October 15th for consulting services commencing October 1st and ending December 31st. |
[Remainder of page intentionally left blank.]
This Amendment #2 is executed by individuals who are duly authorized to legally bind their respective parties as of the Amendment #2 Effective Date:
| MAGENTA THERAPEUTICS, INC. | NATIONAL MARROW DONOR PROGRAM d/b/a BE THE MATCH BIOTHERAPIES | |||||||
| By: | /s/ Christina Isacson | By: | /s/ Mary Frey | |||||
| Authorized signature | Authorized signature | |||||||
| Christina Isacson | Mary Frey | |||||||
| (Typed/Printed Name) | (Typed/Printed Name) | |||||||
| Title: | Chief Business Officer | Title: | Contracts & Procurement Department | |||||
| Date: | November 13, 2019 | Date: | 11/12/19 | |||||
2